NOBILIS RT+IBMULTI+G+ND

País: Irlanda

Idioma: inglés

Fuente: HPRA (Health Products Regulatory Authority)

Ingredientes activos:

INFECTIOUS BRONCHITIS VIRUS STRAIN M41 INACTIVATED, INFECTIOUS BRONCHITIS VIRUS STRAIN 249G INACTIVATED, AVIAN RHINOTRACHEITIS VIRUS STRAIN BUT1#8544 INACTIVATED, GUMBORO DISEASE VIRUS STRAIN D78 INACTIVATED, NEWCASTLE DISEASE VIRUS STRAIN CLONE 30 INACTIVATED

Disponible desde:

Intervet Ireland Limited

Código ATC:

QI01AA18

Designación común internacional (DCI):

INFECTIOUS BRONCHITIS VIRUS STRAIN M41 INACTIVATED, INFECTIOUS BRONCHITIS VIRUS STRAIN 249G INACTIVATED, AVIAN RHINOTRACHEITIS V

Dosis:

Unknown

formulario farmacéutico:

Emulsion for Injection

tipo de receta:

POM

Grupo terapéutico:

Fowl - Chicken

Área terapéutica:

Avian infectious bronchitis virus vaccine + Newcastle disease virus / paramyxovirus vaccine + Avian

indicaciones terapéuticas:

Immunological - Inactivated vaccine

Estado de Autorización:

Authorised

Fecha de autorización:

2000-08-24

Ficha técnica

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Nobilis RT+IBmulti+G+ND
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Emulsion for injection (water-in-oil)
White to nearly white oily emulsion.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chickens (future breeders)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Active immunisation of breeder chickens for:
-
reduction of infection and prevention of egg drop caused by the Massachusetts serotype of Infectious Bronchitis
virus;
-
reduction of egg drop and egg shell defects caused by the D274/D207 serotype of Infectious Bronchitis virus;
-
reduction of infection caused by Newcastle Disease virus;
-
prevention of respiratory signs and reduction of egg drop and egg shell defects related to Avian Rhinotracheitis
virus;
-
passive immunisation of the progeny of the vaccinated birds against Infectious Bursal Disease for at least the first
four weeks of life.
For Infectious Bronchitis, Newcastle and Avian Rhinotracheitis virus:
Onset of immunity: 4 weeks after vaccination
Duration of immunity: one laying period.
Per dose of 0.5 ml:
ACTIVE SUBSTANCE(S):
ART strain But1#8544
inducing
9.5 log2 ELISA units*
IBV strain M41(Massachusetts)
inducing
5.5 log2 VN units*
IBV strain 249g (D274/D207)
inducing
4.0 log2 VN units*
IBDV strain D78
inducing
14.5 log2 VN units*
NDV strain Clone 30
inducing
4.0 log2 HI units per 1/50th dose*
or containing
50 PD
50
units
* serological response in chickens
ADJUVANT:
Liquid paraffin
215 mg
EXCIPIENTS:
For a full list of excipients, see section 6.1.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 19/11/2015_
_CRN 7021969_
_page number: 1_
4.3 CONTRAINDICATIONS
None
4.4 SPECIAL WARNINGS FOR